
R406
CAS No. 841290-81-1
R406 ( —— )
产品货号. M16127 CAS No. 841290-81-1
R406 是一种有效的 Syk 抑制剂,IC50 为 41 nM,强烈抑制 Syk,但不抑制 Lyn,其效力比 Flt3 低 5 倍。阶段1。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥446 | 有现货 |
![]() ![]() |
5MG | ¥697 | 有现货 |
![]() ![]() |
10MG | ¥1239 | 有现货 |
![]() ![]() |
25MG | ¥2697 | 有现货 |
![]() ![]() |
50MG | ¥4010 | 有现货 |
![]() ![]() |
100MG | ¥5824 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称R406
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述R406 是一种有效的 Syk 抑制剂,IC50 为 41 nM,强烈抑制 Syk,但不抑制 Lyn,其效力比 Flt3 低 5 倍。阶段1。
-
产品描述R406 is a potent Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 1.
-
体外实验R406 inhibits adenosine A3 receptor (IC50=0.081 μM), adenosine transporter (IC50=1.84 μM), and monoamine transporter (IC50=2.74 μM).R406 inhibits Huh7 hepatocyte, A549 epithelial, and H1299 lung cancer lines with EC50s of 15.1, 2.9 and 6.3 μM, respectively.R406 inhibits phosphorylation of Syk substrate LAT in mast cells and BLNK/SLP65 in B cells. Western Blot AnalysisCell Line:Cultured human mast cells (CHMC)Concentration:0.016, 0.08, 0.4, 2 μM Incubation Time:40 minutes Result:Inhibited all other kinases tested at 5 to 100 fold less potency than Syk as judged by phosphorylation of target proteins.
-
体内实验R406 (5 and 10 mg/kg) shows efficacy in the amelioration of the Arthus reaction and in reducing clinical symptoms in the collagen antibody-induced arthritis (CAIA) and K/BxN models of rheumatoid arthritis (RA). Immune complex (IC)-mediated inflammation is reduced by inhibition of Fc receptor signaling with R406. Animal Model:Female Balb/c mice (6-8 weeks) with CAIADosage:5 and 10 mg/kg Administration:Administered orally, b.i.d, for 14 days, starting 4 hours after antibody challenge on day 0. Result:Reduced inflammation and swelling, and the arthritis progressed more slowly in treated animals than in vehicle controls.Animal Model:Female C57BL/6 mice with arthritis Dosage:10 mg/kg Administration:Administered orally one hour before serum injection; b.i.d; for 13 days Result:Delayed the onset and reduced the severity of clinical arthritis. Paw thickening and clinical arthritis were reduced by approximately 50%.
-
同义词——
-
通路Angiogenesis
-
靶点Syk
-
受体Syk
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number841290-81-1
-
分子量628.63
-
分子式C22H23FN6O5·C6H6O3S
-
纯度>98% (HPLC)
-
溶解度DMSO:126 mg/mL (200.43 mM); Ethanol:8 mg/mL (12.72 mM); Water:<1 mg/mL (<1 mM)
-
SMILESOS(=O)(=O)C1=CC=CC=C1.COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4)C=C3)=N2)=CC(OC)=C1OC
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Braselmann S, et al. J Pharmacol Exp Ther, 2006, 319(3), 998-1008.
产品手册




关联产品
-
TAK-659
TAK-659(TAK659,Mivavotinib)是一种有效的、选择性的、口服的 SYK 抑制剂,IC50 为 3.2 nM。
-
TAK-659 hydrochlorid...
TAK-659 盐酸盐(Mivavotinib,TAK659)是一种有效的、选择性的、口服的 SYK 抑制剂,IC50 为 3.2 nM。
-
BAY 61-3606 dihydroc...
一种有效的、ATP 竞争性的、可逆的、高选择性的 Syk 酪氨酸激酶抑制剂,Ki 为 7.5 nM。